Clinical definition for multiple sclerosis treatment trials
Author:
- 1 January 1994
- journal article
- review article
- Published by Wiley in Annals of Neurology
- Vol. 36 (S1) , S73-S79
Abstract
Clinically, the Schumacher Panel criteria remain the best set of diagnostic criteria. Two subsets therein are definable, i.e., exacerbating–remitting (ER) and chronic progressive (CP), with the latter subdivided into progressive from onset and secondarily progressive. A clinically stable stage can also be recognized. It has been customary in treatment trials to separate ER and CP patients. End point for the latter is a comparison of neurologic status at the end of the trial with that entry. A similar assessment can be made for ER patients. With this criterion both types could be included in a single study. One could also, though, treat the exacerbation in an acute study or assess whether exacerbations can be prevented in a long‐term trial. Most clinicians no longer consider monophasic disease as multiple sclerosis (MS). Depending on clinical extent, such patients are divisible into acute disseminated encephalomyelitis, Devic disease, transverse myelopathy, or optic neuritis. Each subgroup could be studied as with an acute exacerbation or in long term as to whether future and different neurologic insults can be prevented. One measure of neurologic status is the Disability Status Scale (DSS), which grades clinical impairment due to MS on a 0 (normal) to 10 (death due to MS) basis. The expanded DSS (EDSS) subdivides each step 1 through 9 into two. Type and severity of neurologic impairment is defined by graded involvement in the following eight functional systems (FS): pyramidal, cerebellar, brainstem, sensory, bowel and bladder, visual, cerebral, and other. Frequency and severity of each FS correlates strongly with DSS scores. In treatment trials, change of one full step on (E)DSS can be used to define improvement or worsening for each patient.Keywords
This publication has 22 references indexed in Scilit:
- Risk Factors, Course, and Prognosis of Multiple Selerosis1988
- Problems and Pitfalls in Treatment Trials of Multiple SclerosisNeuroepidemiology, 1987
- The incidence of optic neuritis and its prognosis for multiple sclerosisActa Neurologica Scandinavica, 1983
- Rating neurologic impairment in multiple sclerosisNeurology, 1983
- A prospective study of the risk of developing multiple sclerosis in optic neuritis in a tropical and sub-tropical area.Journal of Neurology, Neurosurgery & Psychiatry, 1983
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983
- FACTORS INFLUENCING THE RISK OF MULTIPLE SCLEROSIS DEVELOPING IN PATIENTS WITH OPTIC NEURITISBrain, 1978
- Acute optic neuritis and the prognosis for multiple sclerosis.Journal of Neurology, Neurosurgery & Psychiatry, 1976
- STUDIES ON NATURAL HISTORY OF MULTIPLE SCLEROSISActa Neurologica Scandinavica, 1968
- PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSISAnnals of the New York Academy of Sciences, 1965